CONTINENTAL GENERAL INSURANCE COMPANY et al v. MALLINCKRODT PLC et al

3:23-cv-03662

Class Action

September 23, 2024
Mallinckrodt Brass Can't Avoid Investor Suit Over 2nd Ch. 11

A New Jersey federal judge ruled Monday that senior leaders of drugmaker Mallinckrodt cannot escape a lawsuit brought by shareholders alleging the company tricked them into thinking it had recovered from bankruptcy and would make a $200 million payment to opioid claimants, finding the investors sufficiently pleaded securities law violations.
September 21, 2023
Pomerantz To Be Lead Counsel In Mallinckrodt Investor Suit

Pomerantz LLP has been appointed lead counsel in a suit asserting insolvent drugmaker Mallinckrodt PLC tricked investors into thinking it had recovered from bankruptcy and would make a $200 million payment to an opioid fund, a New Jersey federal judge said in an order.
September 06, 2023
Pomerantz Seeks To Lead Mallinckrodt Investor Suit

Two corporate investors have asked a New Jersey federal judge to name Pomerantz LLP as lead counsel in their suit accusing Mallinckrodt PLC of deceiving shareholders into believing the drugmaker had bounced back from bankruptcy and would be able to pay $200 million to an opioid fund.
July 10, 2023
Mallinckrodt Hit With Investor Suit After Mulling 2nd Ch. 11

Drugmaker Mallinckrodt PLC deceived shareholders that it had bounced back from bankruptcy and would be able to pay $200 million to an opioid fund, according to a proposed class action filed after the company announced that it is considering filing for Chapter 11 for a second time.